future. For the performance of business in 2018, the Company foresee an opportunities to grow 1) Mobile Phone Distributor Business: The Core Company, Jaymart Mobile, still pursue its target to sale more
continued due to JMT had a non-performing loan that would fully amortized investment value in the late of Q2/2019. JMT still pursue its growth objective to achieve a record high in performance for the third
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a
Sheet but also provides it the necessary resources to pursue its inorganic growth strategy. The net debt to equity ratio has reduced to 0.80 despite acquisitions completed in the first three quarters of
printing-media entrepreneurs to suffer losses in the present. After this sale of shares of NINE, the Company shall pursue its strategy and policy, focusing on the core business operation that the Company
Company shall pursue its strategy and policy, focusing on the core business operation that the Company truly has knowledge and expertise in as the strength, which consists of printing media (Bangkok
เครื่องแม่ข่าย (server) และอุปกรณ์ที่ใช้ปฏิบัติงาน (endpoint) ข้อ 8.5 การกำหนดนโยบายและมาตรการรักษาความปลอดภัยสำหรับการใช้งานอุปกรณ์ส่วนตัว (bring your own device : BYOD) ข้อ 8.9 การประเมินช่องโหว่ทางเทคนิค